ANIP ANI Pharmaceuticals, Inc. Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

ANIP [NASD]

ANI Pharmaceuticals, Inc.

Healthcare | Drug Manufacturers - Specialty & Generic | USA

statements

Index	-	P/E	-	EPS (ttm)	-1.70	Insider Own	0.60%	Shs Outstand	11.97M	Perf Week	0.11%
Market Cap	322.10M	Forward P/E	7.14	EPS next Y	3.83	Insider Trans	16.46%	Shs Float	9.51M	Perf Month	-3.26%
Income	-20.30M	PEG	-	EPS next Q	0.89	Inst Own	79.40%	Short Float	5.79%	Perf Quarter	-9.83%
Sales	197.50M	P/S	1.63	EPS this Y	-61.80%	Inst Trans	-1.63%	Short Ratio	7.40	Perf Half Y	-31.72%
Book/sh	15.99	P/B	1.71	EPS next Y	6.31%	ROA	-4.40%	Target Price	38.33	Perf Year	-65.17%
Cash/sh	2.35	P/C	11.63	EPS next 5Y	2.20%	ROE	-9.90%	52W Range	25.23 - 80.87	Perf YTD	-55.70%
Dividend	-	P/FCF	7.37	EPS past 5Y	-28.10%	ROI	4.80%	52W High	-66.22%	Beta	1.29
Dividend %	-	Quick Ratio	1.30	Sales past 5Y	29.80%	Gross Margin	61.90%	52W Low	8.28%	ATR	1.15
Employees	338	Current Ratio	2.00	Sales Q/Q	-10.80%	Oper. Margin	-8.30%	RSI (14)	39.95	Volatility	3.95% 3.67%
Optionable	Yes	Debt/Eq	0.99	EPS Q/Q	-295.20%	Profit Margin	-10.30%	Rel Volume	0.77	Prev Close	27.79
Shortable	Yes	LT Debt/Eq	0.93	Earnings	Aug 06 BMO	Payout	-	Avg Volume	74.29K	Price	27.32
Recom	2.00	SMA20	-5.50%	SMA50	-7.01%	SMA200	-27.69%	Volume	57,221	Change	-1.69%

May-07-20

Downgrade

Cantor Fitzgerald

Overweight → Neutral

Sep-12-19

Initiated

Guggenheim

Buy

May-10-19

Downgrade

Raymond James

Strong Buy → Outperform

$73 → $82

Oct-16-17

Reiterated

Canaccord Genuity

Buy

$60 → $66

Jul-31-17

Initiated

Canaccord Genuity

Buy

$60

Feb-22-17

Downgrade

ROTH Capital

Buy → Neutral

Jun-23-16

Initiated

Raymond James

Strong Buy

$68

May-24-16

Downgrade

Standpoint Research

Buy → Hold

Nov-13-15

Initiated

Standpoint Research

Buy

$54

Sep-28-15

Upgrade

ROTH Capital

Neutral → Buy

$67 → $60

Aug-05-15

Reiterated

Oppenheimer

Outperform

$74 → $65

Aug-04-15

Reiterated

ROTH Capital

Neutral

$70 → $67

Jul-31-15

Reiterated

Oppenheimer

Outperform

$72 → $74

Jul-15-15

Reiterated

ROTH Capital

Neutral

$60 → $70

Jun-23-15

Reiterated

Oppenheimer

Outperform

$61 → $67

May-18-15

Reiterated

ROTH Capital

Neutral

$78 → $60

May-06-15

Reiterated

Oppenheimer

Outperform

$69 → $61

Apr-10-15

Downgrade

ROTH Capital

Buy → Neutral

$78

Feb-26-15

Reiterated

ROTH Capital

Buy

$65 → $78

Feb-18-15

Reiterated

Oppenheimer

Outperform

$58 → $69

Oct-28-20 12:32PM	Analysts Estimate ANI Pharmaceuticals (ANIP) to Report a Decline in Earnings: What to Look Out for Zacks
Sep-10-20 07:00PM	ANI Pharmaceuticals Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Aug-06-20 08:35AM	ANI Pharmaceuticals (ANIP) Q2 Earnings Miss Estimates Zacks
06:50AM	ANI Pharmaceuticals Reports Second Quarter 2020 Results Business Wire
06:45AM	ANI Pharmaceuticals Appoints Experienced Pharmaceutical Executives, Jeanne Thoma and Antonio "Tony" Pera to Board of Directors Business Wire
Aug-03-20 06:50AM	ANI Pharmaceuticals Names Nikhil Lalwani as President and Chief Executive Officer Business Wire
Jul-30-20 06:50AM	ANI Pharmaceuticals Schedules Conference Call to Discuss Second Quarter 2020 Financial Results Business Wire
Jul-29-20 12:33PM	Earnings Preview: ANI Pharmaceuticals (ANIP) Q2 Earnings Expected to Decline Zacks
Jul-08-20 07:38AM	New Strong Sell Stocks for July 8th Zacks -5.09%
Jul-06-20 08:30AM	ANI Pharmaceuticals Announces Acquisition of Fluconazole Tablets PR Newswire
Jul-04-20 08:54PM	Hedge Funds Are Selling ANI Pharmaceuticals Inc (ANIP) Insider Monkey
Jun-30-20 08:30AM	ANI Pharmaceuticals Announces Launch of Mexiletine Hydrochloride Capsules PR Newswire
Jun-14-20 11:38PM	Edited Transcript of ANIP.OQ earnings conference call or presentation 7-May-20 2:30pm GMT Thomson Reuters StreetEvents
Jun-01-20 08:30AM	ANI Pharmaceuticals Provides Update on Recent Regulatory Filing PR Newswire
May-09-20 08:21AM	Earnings Release: Here's Why Analysts Cut Their ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Price Target To US$45.67 Simply Wall St.
May-08-20 06:30PM	ANI Pharmaceuticals Inc (ANIP) Q1 2020 Earnings Call Transcript Motley Fool
May-07-20 09:55AM	ANI Pharmaceuticals (ANIP) Q1 Earnings and Revenues Surpass Estimates Zacks -7.85%
08:30AM	ANI Pharmaceuticals Reports First Quarter 2020 Results and Appoints Interim CEO PR Newswire
May-01-20 11:50AM	Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now? Zacks
Apr-30-20 08:30AM	ANI Pharmaceuticals Schedules Conference Call to Discuss First Quarter 2020 Financial Results PR Newswire
Apr-29-20 08:30AM	ANI Receives Refusal to File Letter from FDA for Cortrophin® Gel PR Newswire -8.50%
Apr-24-20 06:45AM	The ANI Pharmaceuticals (NASDAQ:ANIP) Share Price Is Down 40% So Some Shareholders Are Getting Worried Simply Wall St.
Apr-14-20 08:30AM	ANI Announces Upcoming Departure of CEO PR Newswire -8.98%
Apr-13-20 08:30AM	ANI Announces FDA Acceptance of Supplemental Filing for Cortrophin® Gel 80 U/mL PR Newswire +6.12%
Apr-02-20 08:30AM	ANI Pharmaceuticals Announces Launch of Omega-3-Acid Ethyl Esters Capsules USP PR Newswire
Mar-26-20 08:30AM	ANI Announces Launch of Polyethylene Glycol 3350, 17g/Packet PR Newswire
Mar-24-20 08:30AM	ANI Pharmaceuticals Announces the Filing of a Prior Approval Supplement for Purified Cortrophin® Gel 80 U/mL PR Newswire +24.22%
Mar-11-20 03:37PM	Edited Transcript of ANIP earnings conference call or presentation 27-Feb-20 3:30pm GMT Thomson Reuters StreetEvents
Mar-10-20 06:40AM	A Sliding Share Price Has Us Looking At ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) P/E Ratio Simply Wall St.
Mar-05-20 07:17AM	New Strong Sell Stocks for March 5th Zacks -7.34%
Mar-02-20 08:30AM	ANI Pharmaceuticals Announces FDA Approval of Memantine Hydrochloride Extended-Release Capsules PR Newswire -7.81%
Feb-29-20 07:35AM	Earnings Miss: ANI Pharmaceuticals, Inc. Missed EPS By 53% And Analysts Are Revising Their Forecasts Simply Wall St.
Feb-27-20 10:05AM	ANI Pharmaceuticals (ANIP) Q4 Earnings and Revenues Lag Estimates Zacks -18.68%
08:30AM	ANI Pharmaceuticals Reports Full Year and Fourth Quarter 2019 Results, Provides 2020 Guidance and Remains on Track to Submit Cortrophin® Gel sNDA to FDA in March 2020 PR Newswire
Feb-24-20 12:45PM	3 Fast-Growing CapEx Stocks GuruFocus.com
Feb-21-20 05:25AM	Read This Before Judging ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) ROE Simply Wall St.
Feb-20-20 08:30AM	ANI Pharmaceuticals Schedules Conference Call to Discuss Fourth Quarter and Year-to-Date 2019 Financial Results PR Newswire
Feb-19-20 12:31PM	Earnings Preview: ANI Pharmaceuticals (ANIP) Q4 Earnings Expected to Decline Zacks
Feb-12-20 08:30AM	ANI Announces Launch of Sulfamethoxazole and Trimethoprim Oral Suspension USP 200 mg/40 mg per 5 mL PR Newswire
Jan-24-20 08:30AM	ANI Announces Launch of Tolterodine Extended-Release Capsules PR Newswire
Jan-16-20 08:30AM	ANI Pharmaceuticals Announces FDA Approval of Potassium Citrate Extended-Release Tablets USP PR Newswire
05:39AM	Is ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) CEO Pay Justified? Simply Wall St.
Jan-14-20 08:30AM	ANI Announces Launch of Paliperidone Extended-Release Tablets PR Newswire
Jan-09-20 08:30AM	ANI Pharmaceuticals Announces Acquisition of Commercial and Pipeline Generic Products from Amerigen Pharmaceuticals, Ltd. PR Newswire
Dec-19-19 10:09AM	4 Drug/Biotech Outperformers That May Lose Steam in 2020 Zacks
Dec-18-19 08:30AM	ANI Pharmaceuticals Announces Launch of Bretylium Tosylate Injection, USP 50 mg/mL PR Newswire
Dec-11-19 01:55PM	Is ANI Pharmaceuticals Inc (ANIP) Going To Burn These Hedge Funds ? Insider Monkey
05:06AM	Before You Buy ANI Pharmaceuticals, Inc. (NASDAQ:ANIP), Consider Its Volatility Simply Wall St.
Dec-04-19 09:21AM	New Strong Sell Stocks for December 4th Zacks
07:45AM	Moving Average Crossover Alert: ANI Pharmaceuticals Zacks
Nov-26-19 08:30AM	ANI Pharmaceuticals to Present at Evercore ISI 2nd Annual HealthCONx Conference PR Newswire
Nov-22-19 05:19PM	Edited Transcript of ANIP earnings conference call or presentation 6-Nov-19 3:30pm GMT Thomson Reuters StreetEvents
Nov-11-19 06:25AM	Estimating The Intrinsic Value Of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Simply Wall St.
Nov-06-19 09:55AM	ANI Pharmaceuticals (ANIP) Lags Q3 Earnings and Revenue Estimates Zacks -23.75%
08:30AM	ANI Pharmaceuticals Reports Third Quarter Results PR Newswire
08:21AM	The Daily Biotech Pulse: Sesen Rallies On Positive FDA Meeting, Supernus Flunks Late-Stage ADHD Trial, GW Pharma Earnings Benzinga
Oct-31-19 08:30AM	ANI Announces Plans to Launch Bretylium Tosylate Injection, USP 500mg/10ml (50mg/ml) for Ventricular Arrhythmias PR Newswire
Oct-30-19 08:30AM	ANI Pharmaceuticals Schedules Conference Call to Discuss Third Quarter and Year-to-Date 2019 Financial Results PR Newswire
Oct-29-19 10:33AM	ANI Pharmaceuticals (ANIP) to Report Q3 Results: Wall Street Expects Earnings Growth Zacks
08:30AM	ANI Pharmaceuticals announces the launch of ANI Global Source, its contract development and manufacturing business PR Newswire
Oct-28-19 04:14PM	Here is What Hedge Funds Think About ANI Pharmaceuticals Inc (ANIP) Insider Monkey
Oct-12-19 08:26AM	Does ANI Pharmaceuticals (NASDAQ:ANIP) Deserve A Spot On Your Watchlist? Simply Wall St.
Oct-11-19 12:18PM	Zacks.com featured highlights include: Assurant, Opera, ANI, eXp and Avista Zacks
Oct-10-19 10:37AM	Zacks.com featured highlights include: Assurant, Opera, ANI, eXp and Avista Zacks
Oct-09-19 09:09AM	5 Stocks to Consider as New Analysts Initiate Coverage Zacks
Oct-03-19 08:30AM	ANI Announces Positive Clinical Results from Cortrophin® Gel Cortisol Response Study PR Newswire
Oct-02-19 08:30AM	ANI Pharmaceuticals Announces Launch of Aspirin and Extended Release Dipyridamole Capsules, 25mg/200mg PR Newswire
Sep-29-19 11:39AM	Hedge Fund Mangrove Partners Top Stock Picks Insider Monkey
Sep-12-19 06:57AM	ANI Pharmaceuticals (NASDAQ:ANIP) Takes On Some Risk With Its Use Of Debt Simply Wall St.
Sep-11-19 08:30AM	ANI Pharmaceuticals Announces Launch of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5mL PR Newswire
Sep-05-19 06:43PM	Edited Transcript of ANIP earnings conference call or presentation 7-Aug-19 2:30pm GMT Thomson Reuters StreetEvents
Aug-13-19 08:08AM	ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Delivered A Weaker ROE Than Its Industry Simply Wall St.
Aug-07-19 01:23PM	ANI Pharmaceuticals Inc (ANIP) Q2 2019 Earnings Call Transcript Motley Fool -12.04%
09:45AM	ANI Pharmaceuticals (ANIP) Q2 Earnings Surpass Estimates Zacks
08:30AM	ANI Pharmaceuticals Reports Second Quarter Results PR Newswire
Jul-31-19 08:30AM	ANI Pharmaceuticals Schedules Conference Call to Discuss Second Quarter and Year-to-Date 2019 Financial Results PR Newswire
Jul-30-19 10:38AM	ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Q2 Release Zacks
Jul-09-19 02:38PM	How Much is ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) CEO Getting Paid? Simply Wall St.
Jun-27-19 04:11PM	Hedge Funds Piled Into This Stock Right Before Its Double Digit Gains Insider Monkey
Jun-25-19 08:30AM	ANI Pharmaceuticals Announces Launch of Ranitidine Capsules PR Newswire
Jun-20-19 10:30AM	ANI Pharmaceuticals Announces Approval of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5ml PR Newswire
Jun-18-19 08:00AM	ANI Pharmaceuticals Expands Generic Pipeline with Acquisition of Seven Development Stage Drug Products from Coeptis Pharmaceuticals, Inc. PR Newswire
Jun-12-19 08:30AM	ANI Pharmaceuticals to Present at Raymond James Life Sciences and MedTech Conference PR Newswire
May-31-19 12:38PM	Is ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Trading At A 48% Discount? Simply Wall St.
May-16-19 09:00AM	What Makes ANI (ANIP) a New Buy Stock Zacks
May-12-19 11:52AM	Edited Transcript of ANIP earnings conference call or presentation 9-May-19 2:30pm GMT Thomson Reuters StreetEvents
May-10-19 10:23AM	ANI Pharmaceuticals Inc (ANIP) Q1 2019 Earnings Call Transcript Motley Fool
May-09-19 01:14PM	Did Hedge Funds Drop The Ball On ANI Pharmaceuticals Inc (ANIP) ? Insider Monkey
08:39AM	ANI: 1Q Earnings Snapshot Associated Press
08:30AM	ANI Pharmaceuticals Reports First Quarter 2019 Results and Reaffirms Guidance PR Newswire
May-02-19 08:30AM	ANI Pharmaceuticals Schedules Conference Call to Discuss First Quarter 2019 Financial Results PR Newswire
May-01-19 05:45PM	ANI Pharmaceuticals (ANIP) Dips More Than Broader Markets: What You Should Know Zacks
Apr-30-19 09:00AM	The Zacks Analyst Blog Highlights: Bed Bath & Beyond, ANI, DXP, Foot Locker and ACI Zacks
08:32AM	What's in Store for ANI Pharmaceuticals (ANIP) Q1 Earnings? Zacks
Apr-29-19 08:05AM	American Economy Hits the Gas: 5 Top Gainers Zacks
Apr-27-19 09:04AM	If You Had Bought ANI Pharmaceuticals (NASDAQ:ANIP) Shares Five Years Ago You'd Have Made 115% Simply Wall St.
Apr-26-19 11:11AM	Medicines Company (MDCO) Q1 Loss Narrows, Inclisiran in Focus Zacks
Apr-25-19 05:45PM	ANI Pharmaceuticals (ANIP) Dips More Than Broader Markets: What You Should Know Zacks
09:31AM	Alexion (ALXN) Q1 Earnings Beat Estimates, Guidance Raised Zacks
Apr-23-19 09:34AM	Zacks.com featured expert Kevin Matras highlights: Advanced Emissions Solutions, Verint Systems, Great Lakes Dredge & Dock, ANI Pharmaceuticals and ACI Worldwide Zacks

ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncolytics (anti-cancers), hormones and steroids, and other formulations. The company offers pharmaceuticals for the treatment of breast cancer, hypertension, ventricular arrhythmias, stage D2 metastatic carcinoma of the prostate, depression, diarrhea, infections, vasomotor symptoms of menopause, pain caused by osteoarthritis and rheumatoid arthritis, epilepsy, arrhythmia, obsessive-compulsive disorder and social anxiety disorder, ulcerative colitis, salt and fluid retention, manic episodes of bipolar disorder, ulcerative colitis, proctosigmoiditis, ocular conditions, metastatic prostate cancer, arrhythmia, migraine headache, and enterocolitis caused by staphylococcus aureus. It also provides aspirin and extended-release dipyridamole; Cholestyramine, an adjunctive therapy to diet for the reduction of elevated serum cholesterol; Ezetimibe-Simvastatin to lower high cholesterol and triglyceride levels; Fenofibrate, a peroxisome proliferator receptor alpha activator; Hydrocortisone rectal cream for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses; Morphine Sulfate, an oral solution for acute and chronic pain management; Nimodipine to enhance neurological outcomes; and Terbutaline Sulfate for the prevention and reversal of bronchospasm. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract manufacturing for other pharmaceutical companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was founded in 2001 and is headquartered in Baudette, Minnesota.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Walsh Patrick D	CHAIRMAN, INTERIM PRES. & CEO	Aug 10	Buy	30.78	10,000	307,790	30,096	Aug 12 04:18 PM
HAUGHEY THOMAS	Director	Mar 04	Buy	45.05	3,000	135,150	11,291	Mar 05 06:01 PM
HAUGHEY THOMAS	Director	Mar 03	Buy	45.18	2,000	90,360	8,291	Mar 05 06:01 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience